NIAGEN BIOSCIENCE INC

Niagen Bioscience Inc. develops and markets Niagen®, a branded form of nicotinamide riboside (NR), an ingredient sold as a dietary supplement and ingredient for consumer health products. The company's core business is the commercial exploitation of animals through animal testing. Niagen® has been tested on animals to support its regulatory submissions and marketing claims. The ingredient has achieved regulatory acceptance by the U.S. FDA, Health Canada, the European Commission, and other bodies, a process typically reliant on animal data to establish safety. In 2025, the National Advertising Division (NAD) reviewed claims about orally ingested NAD+ precursors, noting the absence of competent human evidence, which underscores the historical reliance on animal studies in this product category. The company's intellectual property and market position are built on research involving animal exploitation.